NCI-Navy Medical Oncology Branch cell line data base - PubMed (original) (raw)
doi: 10.1002/jcb.240630505.
B E Johnson, D C Ihde, A F Gazdar, D P Carbone, P R McClintock, R I Linnoila, M J Matthews, P A Bunn Jr, D Carney, J D Minna, J L Mulshine
Affiliations
- PMID: 8806092
- DOI: 10.1002/jcb.240630505
NCI-Navy Medical Oncology Branch cell line data base
R M Phelps et al. J Cell Biochem Suppl. 1996.
Abstract
The cell line data base described in this paper includes both clinical information about the patients from whom the cell lines were derived and information about the in vitro analyses performed of the cell lines. The cell line data base has evolved as a part of a systematic effort by a research group at the NCI since 1976 to generate human cell lines as biological tools to study cancer and other diseases. The cell lines were generated from clinical specimens obtained as part of a series of Institutional Review Board-approved clinical protocols. The preponderance of the data is on lung cancer cell lines, though a broad range of other cancers are represented. A bank of over 300 human cell lines including cancer cell and in some instances autologous B-lymphoblastoid cells from the NCI-VA and NCI-Navy Medical Oncology Branch are reposited at the American Type Culture Collection. The cell lines are available for the research community. The entire data base is available on the American Type Culture Collection Web Site (WWW:http:@www.atcc.org/).
Similar articles
- Coming soon: a global grid for cancer research.
Bouchie A. Bouchie A. Nat Biotechnol. 2004 Sep;22(9):1071-3. doi: 10.1038/nbt0904-1071. Nat Biotechnol. 2004. PMID: 15340462 No abstract available. - NCI series of cell lines: an historical perspective.
Gazdar AF, Minna JD. Gazdar AF, et al. J Cell Biochem Suppl. 1996;24:1-11. doi: 10.1002/jcb.240630502. J Cell Biochem Suppl. 1996. PMID: 8806089 - Cell line banks and their role in cancer research.
Hay RJ, Reid YA, McClintock PR, Chen TR, Macy ML. Hay RJ, et al. J Cell Biochem Suppl. 1996;24:107-30. doi: 10.1002/jcb.240630507. J Cell Biochem Suppl. 1996. PMID: 8806094 Review. - The NCI All Ireland Cancer Conference.
Johnston PG, Daly PA, Liu E. Johnston PG, et al. Oncologist. 1999;4(4):275-277. Oncologist. 1999. PMID: 10545862 - Cell culture methods for the establishment of the NCI series of lung cancer cell lines.
Oie HK, Russell EK, Carney DN, Gazdar AF. Oie HK, et al. J Cell Biochem Suppl. 1996;24:24-31. doi: 10.1002/jcb.240630504. J Cell Biochem Suppl. 1996. PMID: 8806091 Review.
Cited by
- Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?
Healy FM, Turner AL, Marensi V, MacEwan DJ. Healy FM, et al. Front Pharmacol. 2024 Sep 20;15:1441938. doi: 10.3389/fphar.2024.1441938. eCollection 2024. Front Pharmacol. 2024. PMID: 39372214 Free PMC article. Review. - PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer.
Khan S, Cao L, Wiegand J, Zhang P, Zajac-Kaye M, Kaye FJ, Zheng G, Zhou D. Khan S, et al. bioRxiv [Preprint]. 2024 Mar 1:2024.02.27.582353. doi: 10.1101/2024.02.27.582353. bioRxiv. 2024. PMID: 38464204 Free PMC article. Updated. Preprint. - Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs.
Pal Choudhuri S, Girard L, Lim JYS, Wise JF, Freitas B, Yang D, Wong E, Hamilton S, Chien VD, Kim YJ, Gilbreath C, Zhong J, Phat S, Myers DT, Christensen CL, Mazloom-Farsibaf H, Stanzione M, Wong KK, Hung YP, Farago AF, Meador CB, Dyson NJ, Lawrence MS, Wu S, Drapkin BJ. Pal Choudhuri S, et al. Cancer Discov. 2024 May 1;14(5):804-827. doi: 10.1158/2159-8290.CD-23-0656. Cancer Discov. 2024. PMID: 38386926 Free PMC article. - Lack of racial and ethnic diversity in lung cancer cell lines contributes to lung cancer health disparities.
Leon C, Manley E Jr, Neely AM, Castillo J, Ramos Correa M, Velarde DA, Yang M, Puente PE, Romero DI, Ren B, Chai W, Gladstone M, Lamango NS, Huang Y, Offringa IA. Leon C, et al. Front Oncol. 2023 Nov 1;13:1187585. doi: 10.3389/fonc.2023.1187585. eCollection 2023. Front Oncol. 2023. PMID: 38023251 Free PMC article. Review. - A dual role for ERK-1/2 in the regulation of plasmin activity and cell migration in metastatic NSCLC-H1299 cells.
Zeitlmayr S, Cami D, Selmani B, Gudermann T, Breit A. Zeitlmayr S, et al. Arch Toxicol. 2023 Dec;97(12):3113-3128. doi: 10.1007/s00204-023-03600-6. Epub 2023 Sep 15. Arch Toxicol. 2023. PMID: 37712947 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources
Research Materials